Metolazone As Early Add On Therapy For Acute Decompensated Heart Failure
Status:
Withdrawn
Trial end date:
2016-03-01
Target enrollment:
Participant gender:
Summary
The primary objective of the study is to determine efficacy of metolazone as synergistic
therapy with Lasix in patients with acute decompensated heart failure. This will be a
multicenter double blinded randomized placebo- controlled pilot study of the addition of 5 mg
of metolazone per day for 2 days compared to placebo in patients admitted with acute
decompensated heart failure.